30 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 31, 03:43 PM
Scandent Imaging Ltd.

BSE

  • 16.50 0.60 (3.77%)
  • Vol: 250525
  • BSE Code: 516110
  • PREV. CLOSE
    15.90
  • OPEN PRICE
    16.00
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    16.50(205699)

NSE

  • (%)
  • Vol:
  • NSE Code:
  • PREV. CLOSE
  • OPEN PRICE
  • BID PRICE (QTY.)
    ()
  • OFFER PRICE (QTY.)
    ()

Scandent Imaging Ltd. Board Meetings

From date
To date
Source Date Board Meeting Date Details
28-Apr-201702-May-2017 Notice of Board Meeting to be held on Tuesday, 2nd May 2017 to consider the items as specified in the agenda
01-Feb-201710-Feb-2017 Quarterly Results & Scandent Imaging Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on February 10, 2017, inter alia, to consider and approve the following: 1. To consider and approve the un-audited Financial Results for the quarter ended December 31, 2016. 2. To consider and approve Shifting of Registered office of the Company within the local limit of the City.
08-Nov-201611-Nov-2016 Quarterly Results
16-Aug-201613-Aug-2016 Scandent Imaging Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 13, 2016, inter alia, to consider the following: 1. To consider the Audited Annual Financial i.e. Balance Sheet, Statement of Profit & Loss along wit its notes and the Cash Flow Statement for the financial year ending on March 31, 2016; 2. To consider and approve the draft Directors Report of the 22nd Annual General Meeting of the Company; 3. To consider the holding of the ensuing 22nd Annual General Meeting and to fix the date, venue and time; 4. To approve the Draft Notice convening 22nd Annual General Meeting and fix the dates for closure of register of members and Share Transfer Register; 5. To consider and approve the unaudited financial results for the quarter ended June 30, 2016 (Q1) along with the Limited Review Report of the auditors; 6. To consider and approve the appointment of Secretarial Auditor for the Financial year 2016-2017; 7. To consider and approve the appointment of Company Secretary and Compliance officer; 8. To consider and approve the appointment of an Additional Independent Directors; 9. To Consider and approve the revision in remuneration of Managing Director and Whole Time Director; & Quarterly Results
23-May-201628-May-2016 Audited Results & Scandent Imaging Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on 28th May, 2016, inter-alia, to consider and approve the following: 1. To consider and approve the Audited Financial results for the quarter/year ended 31st March, 2016; 2. To consider opening of new Dental Imaging Centers outside India either directly or indirectly through wholly/partly owned subsidiary (ies)/SPV/ Limited libility Partnership / Partnership.
18-Feb-201620-Feb-2016 The Board of Directors of the Company will be held on February 20, 2016, inter alia, to consider and approve the following: 1. To accept the resignation of Ms. Rachana Shridharani as Company Secretary and Compliance Officer. 2. To consider the appointment of Company Secretary and Compliance officer.
02-Feb-201609-Feb-2016 Quarterly Results & Te Board of Directors of the Company will be held on February 09, 2016, inter alia, to consider and approve the following: 1. To consider and approve the un-audited Financial Results for the Quarter ended December 31, 2015. 2. To consider the formation of entity and or acquiring existing entity as a wholly/partly owned subsidiary (ies)/SPV/ Limited Liability Partnership/ Partnership Firm for opening of new Dental Imaging Centers in Mumbai and any other place in India. 3. To consider opening of new Dental Imaging Centers in Mumbai and any other place in India directly or indirectly through wholly/partly owned subsidiary (ies)/SPV/ Limited Liability Partnership/ Partnership Firm. 4. To consider the re-appointment of Dr. Gautam Deshpande - Managing Director of the Company. 5. To consider the appointment of Company Secretary and Compliance officer. 6. To authorize Dr. Gautam Deshpande - Managing Director of the Company to execute listing agreement with the Stock exchange pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations).
02-Nov-201509-Nov-2015 Quarterly Results
11-Aug-201514-Aug-2015 The meeting of the Board of Directors of the Company will be held on August 14, 2015, inter alia, to consider and approve the following: 1. To consider and approve the Annual Audited Financial Results for the year ended March 31, 2015. 2. To consider the holding of the ensuing 21st AnnualMeeting and to fix the date, venue and time. 3. To consider and approve the draft notice of the 21st AnnualMeeting, of the Company and the business to be transacted there at. 4. To consider and approve the draft Directors Report of the 21sl AnnualMeeting of the Company. 5. To fix the dale of the Book Closure for the purpose of AGM. 6. To consider and take on record the unaudited financial results for the quarter ended June 30, 2015 (Q1) along with the Limited Review Report of the auditors. 7. To consider the appointment of Secretarial Auditor. & Audited Results
11-Jun-201517-Jun-2015 The Board of Directors of the Company will be held on June 17, 2015, inter alia, to consider and approve the following: - To Consider the appointment Dr. Sowmya Gautam Deshpande as Additional Director.
10-Jun-201517-Jun-2015 The Board of Directors of the Company will be held on June 17, 2015, inter alia, to consider and approve the following: - To Consider the appointment Dr. Sowmya Gautam Deshpande as Additional Director.
21-May-201529-May-2015 Audited Results
08-May-201511-May-2015 The Board of Directors of the Company will be held on May 11, 2015, inter alia, to consider and approve the following: 1. To Consider the appointment of Company Secretary and Compliance Officer. 2. To Consider expansion of business and raising of funds from eligible investors to the maximum amount of Rs. 25 crores by way of, preferential issue, Qualified institutional placements, Private placement, issue of warrants, or any other financial instruments or securities convertible equity shares or any combination of the securities and authorizing the committee to evaluate same.
22-Jan-201529-Jan-2015 Quarterly Results & The Board of Directors of the Company will be held on January 29, 2015, inter alia : 1. To consider and take on record the unaudited financial results for the quarter/ nine months ended December 31, 2014 (Q3) along with the Limited Review Report of the auditors for the corresponding period. 2. To consider appointment of Independent Director. 3. To consider adoption of Related Party Transaction policy. 4. To consider adoption of whistleblower policy. 5. To consider the resignation of Ms. Kanchan Parab, Company Secretary & Compliance Officer.
19-Dec-201425-Dec-2014 The Board of Directors of the Company will be held on December 25, 2014, inter alia, to consider the change of Name of the Company.
11-Nov-201413-Nov-2014 Quarterly Results (Revised)